欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号ES/H/0141/002
药品名称LUTRATE DEPOT 22,5 mg powder and solvent for prolonged release suspension for injection
活性成分
    • Leuprorelin 22.5 mg
剂型Powder and solvent for prolonged-release suspension for injection
上市许可持有人GP-PHARM, S.A. Carretera Comarcal C-244, Km 22, 08777 Sant Quintí de Mediona- Barcelona (SPAIN)
参考成员国 - 产品名称Spain (ES)
LUTRATE DEPOT 22,5 mg polvo y disolvente para suspension inyectable de liberacion prolongada
互认成员国 - 产品名称
    • Germany (DE)
      Lutrate Depot 22,5 mg Pulver Und Lösungsmittel zur Herstellung einer Injektionssuspension
    • Austria (AT)
      Lutrate 3-Monats-Depot 22,5 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
      LUTRATE® DEPOT
    • Poland (PL)
    • Hungary (HU)
      POLITRATE DEPOT 22,5 mg por és oldószer retard szuszpenziós injekcióhoz
    • Bulgaria (BG)
      Lutrate Depot
    • Czechia (CZ)
      Lutrate Depot 22,5 mg Prášek a rozpouštědlo pro injekční suspenzi s prodlouženým účinkem
许可日期2015/05/04
最近更新日期2025/08/15
药物ATC编码
    • L02AE02 leuprorelin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase